Can Wellbutrin (bupropion) be safely combined with clonazepam, and what are the seizure‑risk and dosing considerations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wellbutrin and Clonazepam Interaction

Wellbutrin (bupropion) can be safely combined with clonazepam in most patients, but the combination requires careful monitoring because both medications independently lower the seizure threshold, creating an additive seizure risk that demands strict adherence to maximum bupropion dosing limits and screening for seizure-predisposing conditions.

Seizure Risk: The Primary Safety Concern

The core interaction between bupropion and clonazepam centers on seizure threshold:

  • Bupropion alone carries a seizure risk of approximately 0.1% (1 in 1,000) at the standard maximum dose of 300 mg/day for smoking cessation or 450 mg/day for depression. 1

  • Clonazepam is an anticonvulsant that raises the seizure threshold, but paradoxically, abrupt discontinuation of benzodiazepines like clonazepam is an absolute contraindication for starting bupropion because withdrawal dramatically increases seizure risk. 1

  • A published case report documented grand mal seizures in a 27-year-old woman taking bupropion ER with clonazepam and lamotrigine, though the patient was on multiple medications including hydrocodone and zolpidem, making causality difficult to establish. 2

  • Case reports of bupropion combined with other agents that lower seizure threshold (clomipramine, clozapine) have documented prolonged seizure activity and generalized tonic-clonic seizures, suggesting that combinations of seizure-threshold-lowering drugs may have additive or synergistic effects. 3, 4

Critical Pre-Treatment Screening

Before combining these medications, verify the patient does not have:

  • Any history of seizure disorder, stroke, brain tumor, head trauma, or brain metastases – these are absolute contraindications to bupropion regardless of clonazepam co-administration. 1

  • Eating disorders (bulimia or anorexia nervosa) – these conditions independently increase seizure risk with bupropion. 1, 5

  • Plans to abruptly discontinue clonazepam – benzodiazepine withdrawal is an absolute contraindication for bupropion use. 1

  • Current or recent MAOI use (within 14 days) – this is a separate absolute contraindication. 1

  • Uncontrolled hypertension – bupropion can elevate blood pressure and heart rate. 1

Dosing Considerations to Minimize Risk

Never exceed maximum bupropion doses when combining with clonazepam:

  • For depression: Maximum 400 mg/day for bupropion SR or 450 mg/day for bupropion XL. 1

  • For smoking cessation: Maximum 300 mg/day (150 mg twice daily of SR formulation) to maintain seizure risk at 0.1%. 1

  • Start with low doses and titrate gradually: Begin bupropion SR at 150 mg once daily for 3 days, then increase to 150 mg twice daily if tolerated. 1

  • For older adults or patients on multiple CNS medications: Start even lower at 37.5 mg every morning, increasing by 37.5 mg every 3 days as tolerated, with a maximum of 300 mg/day. 1

  • Administer the second daily dose of bupropion SR before 3 PM to minimize insomnia risk. 1

Dose Adjustments for Special Populations

  • Moderate to severe hepatic impairment: Maximum 150 mg daily total dose. 1

  • Moderate to severe renal impairment (GFR <90 mL/min): Reduce total daily dose by 50% because bupropion metabolites accumulate renally. 1

Monitoring Parameters

During the first 1–2 weeks and throughout treatment:

  • Assess for new-onset seizure activity, tremor, myoclonus, or any unusual neurological symptoms – these may herald impending seizures. 1

  • Monitor for suicidal ideation, agitation, irritability, or behavioral changes, especially in patients younger than 24 years, as the risk of suicide attempts is highest during the first 1–2 months of antidepressant therapy. 1

  • Check blood pressure and heart rate periodically, especially during the first 12 weeks, as bupropion can cause elevations in both parameters. 1

  • Ensure clonazepam is continued at a stable dose – do not taper or discontinue the benzodiazepine abruptly while the patient is on bupropion. 1

Clinical Advantages of This Combination

Despite the seizure-risk concern, this combination offers therapeutic benefits:

  • Bupropion addresses depression through noradrenergic/dopaminergic pathways, making it particularly beneficial for patients with low energy, apathy, or hypersomnia. 1, 5

  • Clonazepam provides anxiolytic and anticonvulsant effects, which may partially offset bupropion's activating properties and theoretically provide some seizure protection (though this does not eliminate the need for caution). 2

  • Bupropion has significantly lower rates of sexual dysfunction compared to SSRIs and is associated with minimal weight gain or even weight loss. 1, 5

Common Pitfalls to Avoid

  • Do not skip the intensive monitoring window during weeks 1–2 – this period carries the highest risk for emergent suicidal ideation and early adverse effects. 1

  • Do not exceed maximum bupropion doses – seizure risk rises markedly above 450 mg/day for depression or 300 mg/day for smoking cessation. 1

  • Do not abruptly discontinue clonazepam while the patient is on bupropion – taper benzodiazepines gradually if discontinuation is necessary. 1

  • Do not combine bupropion with other medications that lower seizure threshold (e.g., clozapine, clomipramine, tramadol) without extreme caution and neurological consultation. 3, 4

Expected Timeline for Clinical Response

  • Allow 6–8 weeks at therapeutic doses before assessing adequacy of antidepressant response. 1, 5

  • Early improvement in energy levels may occur within the first few weeks due to bupropion's activating properties, but full antidepressant effects require the full 6–8 week trial. 1

  • If no adequate response occurs by 6–8 weeks, modify the treatment approach by adjusting doses, switching agents, or adding augmentation therapy. 1

References

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Extended-release bupropion induced grand mal seizures.

The Journal of the American Osteopathic Association, 2007

Guideline

Cognitive Safety of Antidepressants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.